Skip to search formSkip to main contentSkip to account menu

Leukemia, Myeloid, Accelerated Phase

Known as: Aggressive-Phase Chronic Myeloid Leukemia, Myeloid Leukemia, Chronic, Aggressive-Phase, myelocytic leukemia, accelerated phase chronic 
A phase of chronic myelogenous leukemia characterized by one or more of the following: 1) Myeloblasts accounting for 10-19% of the peripheral blood… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Adult T-cell leukemia-lymphoma (ATL) is a distinct peripheral T-lymphocytic malignancy associated with a retrovirus designated… 
Review
2007
Highly Cited
2007
Highly Cited
2007
Treatment options are limited for patients with imatinib-resistant or -intolerant accelerated phase chronic myeloid leukemia (CML… 
Highly Cited
2004
Highly Cited
2004
Cyclophosphamide, doxorubicin, vincristine, and prednisone, given every 3 weeks (CHOP-21), is standard chemotherapy for… 
Highly Cited
2004
Highly Cited
2004
PURPOSE To determine the response rate, time to disease progression, survival duration and rate, and toxicity with the… 
Highly Cited
2004
Highly Cited
2004
The combination of cyclophosphamide, doxorubicin, vincristine, and prednisone, given every 3 weeks (CHOP-21) is standard… 
Highly Cited
2002
Highly Cited
2002
Chronic myelogenous leukemia (CML) is caused by expression of the BCR-ABL tyrosine kinase oncogene, the product of the t(9;22… 
Highly Cited
2001
Highly Cited
2001
BACKGROUND Surgical resection of malignant pleural mesothelioma is reported to have up to an 80% rate of local recurrence. We… 
Highly Cited
1987
Highly Cited
1987
Normal haematopoietic cell regulation involves interaction between marrow stromal cells and haematopoietic progenitor cells1…